乌鲁木齐市新增确诊病例和无症状感染者总数出现下降

2020-08-01 李志浩 新华社

乌鲁木齐市疾控中心主任芮宝玲8月1日表示,7月31日乌鲁木齐市新增新冠肺炎确诊病例和无症状感染者总数较前几日出现一定程度下降,但全市疫情防控形势依然复杂严峻,绝不能有丝毫放松,绝不能掉以轻心。

乌鲁木齐市疾控中心主任芮宝玲8月1日表示,7月31日乌鲁木齐市新增新冠肺炎确诊病例和无症状感染者总数较前几日出现一定程度下降,但全市疫情防控形势依然复杂严峻,绝不能有丝毫放松,绝不能掉以轻心。

在新疆维吾尔自治区人民政府新闻办公室8月1日举办的新闻发布会上,芮宝玲表示,希望社会各界和广大市民继续理解、支持、配合疫情防控,严格落实居家管理措施。居家期间,要多开窗、勤通风、勤洗手、定时消毒,做好家庭清洁卫生,家庭成员要保持一定安全距离,吃饭时应使用公筷公勺。如果出现发烧、咳嗽、乏力等不适症状,要及时联系社区工作人员。

芮宝玲通报,7月31日0时至24时,乌鲁木齐市报告新增新冠肺炎确诊病例31例,新增无症状感染者8例;当日,新增治愈出院确诊病例7例,新增无症状感染者解除医学观察7例。7月15日0时至7月31日24时,乌鲁木齐市累计治愈出院确诊病例16例,无症状感染者解除医学观察16例。

截至7月31日24时,新疆(含兵团)现有确诊病例547例(危重症5例、重症25例),其中乌鲁木齐市544例、喀什地区1例(乌鲁木齐市输入)、昌吉回族自治州1例(乌鲁木齐市输入)、兵团1例;现有无症状感染者109例,其中乌鲁木齐市107例、兵团1例、昌吉回族自治州1例(乌鲁木齐市输入);尚有14540人正在接受医学观察。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1987754, encodeId=9c30198e754d7, content=<a href='/topic/show?id=4b14233544e' target=_blank style='color:#2F92EE;'>#乌鲁木齐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23354, encryptionId=4b14233544e, topicName=乌鲁木齐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sun Aug 30 02:33:58 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353291, encodeId=398c13532918d, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 03 13:33:58 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485124, encodeId=ee1814851247c, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Mon Aug 03 13:33:58 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805797, encodeId=70a8805e9707, content=希望尽快控制, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Sun Aug 02 21:05:00 CST 2020, time=2020-08-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1987754, encodeId=9c30198e754d7, content=<a href='/topic/show?id=4b14233544e' target=_blank style='color:#2F92EE;'>#乌鲁木齐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23354, encryptionId=4b14233544e, topicName=乌鲁木齐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sun Aug 30 02:33:58 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353291, encodeId=398c13532918d, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 03 13:33:58 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485124, encodeId=ee1814851247c, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Mon Aug 03 13:33:58 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805797, encodeId=70a8805e9707, content=希望尽快控制, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Sun Aug 02 21:05:00 CST 2020, time=2020-08-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1987754, encodeId=9c30198e754d7, content=<a href='/topic/show?id=4b14233544e' target=_blank style='color:#2F92EE;'>#乌鲁木齐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23354, encryptionId=4b14233544e, topicName=乌鲁木齐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sun Aug 30 02:33:58 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353291, encodeId=398c13532918d, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 03 13:33:58 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485124, encodeId=ee1814851247c, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Mon Aug 03 13:33:58 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805797, encodeId=70a8805e9707, content=希望尽快控制, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Sun Aug 02 21:05:00 CST 2020, time=2020-08-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1987754, encodeId=9c30198e754d7, content=<a href='/topic/show?id=4b14233544e' target=_blank style='color:#2F92EE;'>#乌鲁木齐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23354, encryptionId=4b14233544e, topicName=乌鲁木齐)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sun Aug 30 02:33:58 CST 2020, time=2020-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353291, encodeId=398c13532918d, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 03 13:33:58 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485124, encodeId=ee1814851247c, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Mon Aug 03 13:33:58 CST 2020, time=2020-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805797, encodeId=70a8805e9707, content=希望尽快控制, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa1553611, createdName=ms5000000568257380, createdTime=Sun Aug 02 21:05:00 CST 2020, time=2020-08-02, status=1, ipAttribution=)]
    2020-08-02 ms5000000568257380

    希望尽快控制

    0

相关资讯

为什么美国心血管病死亡率下降这么多?原来是这样!

据报道,1970年-1980年美国人平均寿命增加4年,这一成就是美国历史上从未有过的。美国人类健康统计中心公布的数字表明:1968年到1984年这一时期,美国心肌梗死死亡率下降37%,卒中死亡率下降50%,高血压人数降低了30%以上,高血压死亡率下降60%,人均寿命从70岁增至75岁。为什么会出现这样的变化?不得不提到一个人:全世界推广有氧代谢运动的第一人,美国前总统卡特、布什、克林顿都接受过他

Hypertension:唐氏综合症患儿血压下降

由此可见,该数据可潜在用于儿科唐氏综合症患者的评估和治疗。

Diabetes Obes Metab:二甲双胍减轻了2型糖尿病患者餐后血压的下降

总之,二甲双胍可以急剧减弱口服葡萄糖所引起的低血压反应,与增加的GLP-1分泌和胃排空延迟有关,这可能与其有利的心血管效应相关。

小儿支气管异物取出术中异物形成单向活瓣致心率下降1例

患儿,女性,13个月,体重10kg,诊断为左侧支气管异物,病程3d,异物为熟鸡蛋,拟急诊静吸复合麻醉联合气管内表面麻醉下行支气管镜气管异物取出术。

Int J Cardiol:台湾营养与健康调查显示心绞痛患病率下降

由此可见,从1993-1996年期间到2005-2008年期间,AP的患病率显著下降。女性的AP患病率较高,男性患病率随年龄增长而增加,但女性则不然。建议持续监测AP患病率,以更好地了解该疾病的负担。

治疗射血分数下降的心衰,这种新方案更有效!

患者杨某,男,80岁。以“反复胸闷心悸3年余,加重3天”入院。